Composition for respiratory diseases
OwnerSol Gershinventor
Life of this patent
Estimating the term…
Abstract
A composition for the treatment and providing quick relief for respiratory diseases, such as Flu and Asthma. The composition includes reduced Glutathione; Mentha oil; Pyrroloquinoline quinone; Wintergreen oil; sodium nitrate; oxymetazoline hydrochloride; and excipients. The composition is administered through the nasal route.
Claims5
A formulation for treatment of respiratory diseases and providing relief in the symptoms of respiratory diseases, the formulation comprising:
- a composition comprising, by volume percent thereof:
- reduced glutathione 50-80.45%;
- Mentha oil 0.2-4%;
- pyrroloquinoline quinone 10-30%;
- wintergreen oil 0.2-4%;
- sodium nitrate 0.1-0.5%;
- and
- oxymetazoline hydrochloride 0.01-0.10%;
- and
- an amount of excipients.
A nasal dosage form for treatment and relief of respiratory diseases, the nasal dosage form comprising:
- a composition comprising, by volume percent thereof:
- reduced glutathione 50-80.45%;
- Mentha oil 0.2-4%;
- pyrroloquinoline quinone 10-30%;
- wintergreen oil 0.2-4%;
- sodium nitrate 0.1-0.5%;
- and
- oxymetazoline hydrochloride 0.01-0.10%;
- and
- an amount of excipients.
A method for treatment and providing relief in respiratory diseases, the method comprising the steps of:
- providing a formulation comprising a composition and excipients, wherein the composition comprises reduced glutathione, Mentha oil, pyrroloquinoline quinone, wintergreen oil, sodium nitrate, and oxymetazoline hydrochloride;
- and
- administering the formulation composition through a nasal route, wherein, by volume percent of the composition, the reduced glutathione is present in an amount ranging from 50-89.49%;
- the Mentha oil is present in an amount ranging from 0.2-4%;
- the pyrroloquinoline quinone is present in an amount ranging from 10-30%;
- the wintergreen oil is present in an amount ranging from 0.2-4%;
- the sodium nitrate is present in an amount ranging from 0.1-0.5%;
- and the oxymetazoline hydrochloride is present in an amount ranging from 0.01-0.10%.
Dependencies are inferred from the claim text.